In a conversation with Pharmaceutical Executive, Jay Bregman, CEO and co-founder of Andel, discusses the potential impact of the FDA's increased scrutiny on non-FDA approved GLP-1 products, particularly on the competitive landscape for obesity and diabetes therapies
Summary of Nutrient Impacts on Natural GLP-1: Dietitian Andreas Take As a Registered Dietitian, I encourage my clients to focus on building meals, not chasing trends
To learn more about these market drivers, global ingredient supplier Corbion undertook two proprietary surveys of US consumers to learn more about how, and to what extent, food choices and expenditures are being affected by the prevalent use of GLP-1 medications
In fact, some studies found that semaglutide (GLP-1 RA) medications helped people lose an average of 9%-17% of their body weight in a little over a year
If you prefer asynchronous care without video visits, Noom makes it seamless
This route offers the lowest per-milligram pricing but comes with unique considerations
